PL378061A1 - Nowe formy polimorficzne chlorowodorku olanzapiny - Google Patents

Nowe formy polimorficzne chlorowodorku olanzapiny

Info

Publication number
PL378061A1
PL378061A1 PL378061A PL37806104A PL378061A1 PL 378061 A1 PL378061 A1 PL 378061A1 PL 378061 A PL378061 A PL 378061A PL 37806104 A PL37806104 A PL 37806104A PL 378061 A1 PL378061 A1 PL 378061A1
Authority
PL
Poland
Prior art keywords
new polymorphs
new
hydrochloride
olanzapine
olanzapine hydrochloride
Prior art date
Application number
PL378061A
Other languages
English (en)
Inventor
Janos Petho
Jozsef Barkoczy
Nagy Peter Kotay
Gyula Simig
Zsuzsa Szent-Kirallyi
Original Assignee
Egis Gyógyszergyar Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyógyszergyar Rt filed Critical Egis Gyógyszergyar Rt
Publication of PL378061A1 publication Critical patent/PL378061A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL378061A 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny PL378061A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0301082A HU226410B1 (en) 2003-04-22 2003-04-22 Novel polymorphous forms of olanzapine hydrochlorides, process for producing them, use thereof and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
PL378061A1 true PL378061A1 (pl) 2006-02-20

Family

ID=89981318

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04728854T PL1620439T3 (pl) 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny
PL378061A PL378061A1 (pl) 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04728854T PL1620439T3 (pl) 2003-04-22 2004-04-22 Nowe formy polimorficzne chlorowodorku olanzapiny

Country Status (24)

Country Link
US (1) US7951798B2 (pl)
EP (1) EP1620439B1 (pl)
JP (1) JP4763594B2 (pl)
KR (1) KR20060004954A (pl)
CN (2) CN101468999B (pl)
AT (1) ATE401332T1 (pl)
AU (1) AU2004232544B2 (pl)
BG (1) BG109361A (pl)
CA (1) CA2522734C (pl)
CZ (1) CZ2005684A3 (pl)
DE (1) DE602004015096D1 (pl)
DK (1) DK1620439T3 (pl)
EA (1) EA008376B1 (pl)
ES (1) ES2310728T3 (pl)
HR (1) HRP20080479T3 (pl)
HU (1) HU226410B1 (pl)
IL (1) IL171522A (pl)
PL (2) PL1620439T3 (pl)
PT (1) PT1620439E (pl)
SI (1) SI1620439T1 (pl)
SK (1) SK50942005A3 (pl)
UA (1) UA80881C2 (pl)
WO (1) WO2004094433A1 (pl)
ZA (1) ZA200508936B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323459B2 (en) * 2002-12-24 2008-01-29 Teva Pharmaceutical Industries Ltd. Crystal forms, methods for their preparation and method for preparation of olanzapine
SI21850A (sl) * 2004-07-28 2006-02-28 Krka, Tovarna Zdravil, D.D., Novo Mesto Soli olanzapina in njihova pretvorba v prosto bazo olanzapina
AU2005307797B2 (en) * 2004-11-16 2011-06-02 Alkermes Pharma Ireland Limited Injectable nanoparticulate olanzapine formulations
HUP0501046A2 (en) 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
KR20150081370A (ko) * 2006-07-10 2015-07-13 파이온 유케이 리미티드 속효형 벤조디아제핀 염 및 이의 중합체 형태
WO2008151430A1 (en) * 2007-06-14 2008-12-18 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
US20090286294A1 (en) * 2008-04-04 2009-11-19 University Of Massachusetts Methods and Compositions for Improving the Production of Fuels in Microorganisms
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
PT2729474T (pt) * 2011-07-08 2018-06-05 Lilly Co Eli Compostos (tieno[2,3-b][1,5]benzoxazepin-4-il)piperazin-1-ilo tendo actividade dual como agonistas inversos de h1/antagonistas de 5-ht2a
ES2647523T3 (es) * 2013-01-14 2017-12-22 Eli Lilly And Company Compuestos de (tieno[2,3-b][1,5]benzoxazepin-4-il)piperazin-1-ilo de doble actividad como agonistas inversos de H1/antagonistas de 5-HT2A
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
KR101489062B1 (ko) * 2013-03-28 2015-02-02 동아에스티 주식회사 고순도의 올란자핀 및 이의 결정형 ii의 제조방법
JP6940866B2 (ja) * 2017-06-21 2021-09-29 国立研究開発法人情報通信研究機構 半導体光デバイス、半導体光源、光集積回路、及び半導体光デバイスの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
CA2304568C (en) * 1997-09-30 2008-08-12 Eli Lilly And Company Olanzapine pamoate formulations
DE69917663T2 (de) * 1998-09-30 2005-05-25 Eli Lilly And Co., Indianapolis 2-methyl-thieno-benzodiazepin-formulierung
UA80095C2 (en) 2001-07-20 2007-08-27 Lilly Co Eli 2 methyl-thieno-benzodiazepine lyophilized formulation and method for the preparation thereof
ATE504588T1 (de) * 2004-01-27 2011-04-15 Synthon Bv Stabile salze von olanzapin

Also Published As

Publication number Publication date
UA80881C2 (en) 2007-11-12
KR20060004954A (ko) 2006-01-16
ATE401332T1 (de) 2008-08-15
HU0301082D0 (en) 2003-06-28
DE602004015096D1 (de) 2008-08-28
IL171522A (en) 2010-05-31
CA2522734A1 (en) 2004-11-04
ZA200508936B (en) 2008-07-30
HU226410B1 (en) 2008-11-28
AU2004232544B2 (en) 2010-06-03
SI1620439T1 (sl) 2009-06-30
CN100471859C (zh) 2009-03-25
WO2004094433A1 (en) 2004-11-04
HRP20080479T3 (hr) 2008-10-31
US7951798B2 (en) 2011-05-31
SK50942005A3 (sk) 2006-02-02
CN101468999A (zh) 2009-07-01
EA008376B1 (ru) 2007-04-27
HUP0301082A2 (hu) 2004-12-28
JP2006524219A (ja) 2006-10-26
CZ2005684A3 (cs) 2006-01-11
EP1620439A1 (en) 2006-02-01
JP4763594B2 (ja) 2011-08-31
EP1620439B1 (en) 2008-07-16
ES2310728T3 (es) 2009-01-16
PL1620439T3 (pl) 2009-02-27
CN101468999B (zh) 2012-05-09
CN1777613A (zh) 2006-05-24
US20070004706A1 (en) 2007-01-04
BG109361A (bg) 2006-09-29
EA200501633A1 (ru) 2006-04-28
AU2004232544A1 (en) 2004-11-04
PT1620439E (pt) 2008-10-23
CA2522734C (en) 2010-05-25
DK1620439T3 (da) 2008-11-17

Similar Documents

Publication Publication Date Title
AR002719A1 (es) Forma ii polimorfa 2-metil-4-(4-metil-1-piperacinil)-10h-tieno[2,3-b]-[1,5] benzodiacepina(olanzapina) y formulaciones farmaceuticas que las contienen.
SI1620439T1 (sl) Novi polimorfi olanzapin hidroklorida
HUP0000065A2 (hu) Olanzapin-dihidrát D és az azt tartalmazó gyógyszerkészítmények
BG108868A (en) Polymorphs of clopidogrel hydrochloride and their use as antithrombic compounds
SI1513846T1 (sl) Postopek za pripravo olanzapina form I
HUP0203559A3 (en) Polymorphic forms of sertraline hydrochloride, process for their preparation and pharmaceutical compositions containing them
HUP0400991A3 (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i, process for their preparation and pharmaceutical compositions containing them
AU2003251247A1 (en) Methods for preparation of olanzapine polymorphic form i
HUP0105407A3 (en) Triazolo[1,5-a]quinolin derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
MXPA04012200A (es) Proceso para preparacion de olanzapina e intermediario de la misma.
WO2005090359A3 (en) Synthesis of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno[2, 3-b][1,5]benzodiazepine and salts thereof
IS6437A (is) Ný setin pýrazóló [4,3-e]díazepín lyfjasamsetningar sem innihalda þau, notkun sem læknandi afurðir og aðferðir við framleiðslu þeirra
WO2003037903A8 (en) Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2395774A1 (en) New polymorphic forms of olanzapine
WO2007087555A3 (en) Novel polymorph 'form e ' of olanzapine (2-methyl-4- (4-methyl-1-piperazinyl) -10h-thieno [2, 3-b] [1, 5] benzodiazepine) and preparation of the anhydrous non-solvated crystalline polymorphic 'form i' of olanzapine from the polymorphic olanzapine 'form e'
SG113595A1 (en) New benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8] quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
HU0501046D0 (en) Process for the preparation of olanzapine
SE0100295D0 (sv) New compounds
UA84443C2 (ru) Кристаллическая форма 2,3-диметил-8-(2,6-диметилбензиламино)-n-гидроксиэтилимидазо[1,2-а]пиридин-6-карбоксамид мезилата (варианты), способ их получения, фармацевтическая композиция и способ лечения желудочно-кишечных расстройств
ECSP961694A (es) Procedimeinto para preparar olanzapina (caso x - 9992m)
DK1392698T3 (da) Fremgangsmåde til fremstilling af 6-aryl-4H-s-triazolo-[3,4-c]thieno[2,3-e]-1,4-diazepiner
HK1097521A (en) Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
UA86772C2 (en) Process for the preparation of the polymorph form of methyl (s)-(+)-(2-chlorophenyl)-2-(6,7-dihydro-4h-thieno[3,2-c]pyridine-5-yl-acetate hydrogensulfate
HU0600706D0 (en) Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidin-4-yl amines, pharmaceutically acceptable salts of them, process for their preparation and pharmaceutical compositions containing the same
HK1097522A (en) Pyrrolo[2,3-b]pyridine derivatives active as kinase inhibitors, process for their preparation and pharmaceutical composition comprising them

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)